Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Visninger
• 06/15/23
0
0
Indlejre
administrator
Abonnenter
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer